The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: Efficacy and safety data

By Flidel-Rimon Orna   Friedman Smadar   Leibovitz Eugene   Shinwell Eric  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 1, 2006-01 ,pp. : 36-42

Informa Healthcare

Access to resources Recommend Favorite

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

By Choi Seong Hye   Park Kyung Won   Na Duk L.   Han Hyun Jeong   Kim Eun-Joo   Shim Yong S.   Lee Jae-Hong    

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1375-1383

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study*

By Feuerhake Cord   Buchholz Patricia   Kimmich Friedemann  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1037-1043

Informa Healthcare

Access to resources Recommend Favorite

An Open-Label, Randomized, Flexible-Dose, Crossover Study to Assess the Comparative Efficacy and Safety of Sildenafil Citrate and Apomorphine Hydrochloride in Men with Erectile Dysfunction

By  

Urologia Internationalis, Vol. 81, Iss. 4, 2008-12 ,pp. : 409-415

Karger

Access to resources Recommend Favorite

P057: Efficacy and safety of Peginterferon alfa‐2b (40 kD, Y Shape) (Pegberon) in HBeAg‐ positive CHB patients — a phase III, randomized, multicenter, positive‐controlled, open‐label clinical study

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 48-48

John Wiley & Sons Inc

Access to resources Recommend Favorite